Document Information


PMID 17956327  (  )
Title Respiratory plasticity following intermittent hypoxia: roles of protein phosphatases and reactive oxygen species.
Abstract Plasticity is an important property of the respiratory control system. One of the best-studied models of respiratory plasticity is pLTF (phrenic long-term facilitation). pLTF is a progressive increase in phrenic motor output lasting several hours following acute exposure to intermittent hypoxia. Similar to many other forms of neuroplasticity, pLTF is pattern-sensitive; it is induced by intermittent, but not sustained hypoxia of similar cumulative duration. Our understanding of the cellular/synaptic mechanisms underlying pLTF has increased considerably in recent years. Here, we review accumulating evidence suggesting that the pattern-sensitivity of pLTF arises substantially from differential reactive oxygen species formation and subsequent protein phosphatase inhibition during intermittent compared with sustained hypoxia in or near phrenic motor neurons. A detailed understanding of the cellular/synaptic mechanisms of pLTF may provide the rationale for new pharmacological approaches in the treatment of severe ventilatory control disorders, such as obstructive sleep apnoea and respiratory insufficiency either following spinal cord injury or during neurodegenerative diseases such as amyotrophic lateral sclerosis. Linden Drive, Madison, WI 53706, U.S.A.

NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.



Targets by SciMiner Summary

HUGO ID Symbol Target Name #Occur ActualStr
1033BDNFbrain-derived neurotrophic factor14brain derived neurotrophic factor | BDNF |
391AKT1v-akt murine thymoma viral oncogene homolog 17Akt | PKB | protein kinase b |
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))7SOD | superoxide dismutase |
6871MAPK1mitogen-activated protein kinase 15ERK | MAPKs |
727ARTNartemin3neurotrophic factor |
14874NOX5NADPH oxidase, EF-hand calcium binding domain 53nadph oxidase |
9391PRKAR2Aprotein kinase, cAMP-dependent, regulatory, type II, alpha2protein kinase a |
8032NTRK2neurotrophic tyrosine kinase, receptor, type 22TrkB |
9393PRKCAprotein kinase C, alpha2protein kinase c |
6879MAPK6mitogen-activated protein kinase 62extracellular signal regulated kinase |
12805XDHxanthine dehydrogenase1xanthine oxidase |
4571GRIA1glutamate receptor, ionotropic, AMPA 11glutamate receptor |
9308PPP2R4protein phosphatase 2A activator, regulatory subunit 41protein phosphatase 2a |

 


Targets by SciMiner Full list

HUGO ID Symbol Name ActualStr Score FlankingText
1033BDNFbrain-derived neurotrophic factorBDNF4.2New synthesis and release of BDNF (brain-derived brain-derived neurotrophic factor is necessary and sufficient for pLTF
1033BDNFbrain-derived neurotrophic factorBDNF4.2AIH increases BDNF protein levels near phrenic motor neurons and this increase correlates
1033BDNFbrain-derived neurotrophic factorBDNF4.2The 5-HT-dependent increase in BDNF synthesis following AIH is necessary for pLTF expression since translational
1033BDNFbrain-derived neurotrophic factorBDNF4.2AIH is necessary for pLTF expression since translational inhibition of BDNF mRNA with siRNAs (small small interfering RNAs blocks both increased
1033BDNFbrain-derived neurotrophic factorBDNF4.2mRNA with siRNAs (small small interfering RNAs blocks both increased BDNF protein levels and pLTF receptor tyrosine kinase inhibitors also block
1033BDNFbrain-derived neurotrophic factorBDNF4.2BDNF is sufficient to elicit pLTF since localized application of BDNF
1033BDNFbrain-derived neurotrophic factorBDNF4.2BDNF is sufficient to elicit pLTF since localized application of BDNF protein near phrenic motor neurons elicits long-lasting phrenic motor facilitation
1033BDNFbrain-derived neurotrophic factorBDNF4.2(protein protein kinase C activation stimulating new protein synthesis including BDNF
1033BDNFbrain-derived neurotrophic factorBDNF4.2Released BDNF then activates its high-affinity receptor TrkB (tropomyosin tropomyosin receptor kinase
8032NTRK2neurotrophic tyrosine kinase, receptor, type 2TrkB1.9Released BDNF then activates its high-affinity receptor TrkB (tropomyosin tropomyosin receptor kinase B resulting in the phosphorylation of
6871MAPK1mitogen-activated protein kinase 1ERK0.9(tropomyosin tropomyosin receptor kinase B resulting in the phosphorylation of ERK (extracellular-signal-regulated extracellular-signal-regulated kinase MAPKs (mitogen-activated mitogen-activated protein kinases and Akt
6871MAPK1mitogen-activated protein kinase 1MAPKs0.9B resulting in the phosphorylation of ERK (extracellular-signal-regulated extracellular-signal-regulated kinase MAPKs (mitogen-activated mitogen-activated protein kinases and Akt also called PKB (protein
391AKT1v-akt murine thymoma viral oncogene homolog 1Akt0.8ERK (extracellular-signal-regulated extracellular-signal-regulated kinase MAPKs (mitogen-activated mitogen-activated protein kinases and Akt also called PKB (protein protein kinase B
391AKT1v-akt murine thymoma viral oncogene homolog 1PKB0.8kinase MAPKs (mitogen-activated mitogen-activated protein kinases and Akt also called PKB (protein protein kinase B
6871MAPK1mitogen-activated protein kinase 1ERK0.9phosphatases that may play a role in neural plasticity including ERK and the serine/threonine serine threonine protein phosphatases 1 2A and
6871MAPK1mitogen-activated protein kinase 1ERK0.9is necessary for pLTF 42 and activated forms of both ERK and PKB (Akt) Akt are increased in the ventral cervical
391AKT1v-akt murine thymoma viral oncogene homolog 1PKB0.8for pLTF 42 and activated forms of both ERK and PKB (Akt) Akt are increased in the ventral cervical spinal cord
391AKT1v-akt murine thymoma viral oncogene homolog 1Akt0.842 and activated forms of both ERK and PKB (Akt) Akt are increased in the ventral cervical spinal cord following intermittent
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD0.9SOD (superoxide superoxide dismutase prevent excessive ROS accumulation 46
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD0.9AIH-induced pLTF also requires ROS since pre-treatment with a SOD mimetic abolishes pLTF 23
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD0.9following AIH although changes in superoxide anion levels (e.g e.g SOD mimetic can disrupt levels of other ROS species such as
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD0.9with okadaic acid restores pLTF in animals pre-treated with a SOD mimetic (P.M P.M MacFarlane and G.S Mitchell unpublished work but
1033BDNFbrain-derived neurotrophic factorBDNF4.2Key words brain-derived neurotrophic factor (BDNF), BDNF 5-hydroxytryptamine (5-HT), 5-HT long-term facilitation pattern-sensitivity phosphorylation plasticity
1033BDNFbrain-derived neurotrophic factorBDNF4.2Abbreviations used AIH acute intermittent hypoxia BDNF brain-derived neurotrophic factor ERK extracellular-signal-regulated kinase 5-HT 5-hydroxytryptamine LTF long-term
6871MAPK1mitogen-activated protein kinase 1ERK0.9Abbreviations used AIH acute intermittent hypoxia BDNF brain-derived neurotrophic factor ERK extracellular-signal-regulated kinase 5-HT 5-hydroxytryptamine LTF long-term facilitation pLTF phrenic LTF
391AKT1v-akt murine thymoma viral oncogene homolog 1PKB0.8LTF long-term facilitation pLTF phrenic LTF PKA protein kinase A PKB protein kinase B PKC protein kinase C ROS reactive oxygen
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD0.9kinase B PKC protein kinase C ROS reactive oxygen species SOD superoxide dismutase TrkB tropomyosin receptor kinase B
8032NTRK2neurotrophic tyrosine kinase, receptor, type 2TrkB1.9protein kinase C ROS reactive oxygen species SOD superoxide dismutase TrkB tropomyosin receptor kinase B
727ARTNarteminneurotrophic factor1.0new synthesis and release of bdnf brain derived neurotrophic factor is necessary and sufficient for pltf in vivo [ 21 ].
1033BDNFbrain-derived neurotrophic factorbrain derived neurotrophic factor1.0new synthesis and release of bdnf brain derived neurotrophic factor is necessary and sufficient for pltf in vivo [ 21 ].
9393PRKCAprotein kinase C, alphaprotein kinase c1.0pkc protein kinase c activation] stimulating new protein synthesis including bdnf.
391AKT1v-akt murine thymoma viral oncogene homolog 1protein kinase b1.0igh affinity receptor trkb tropomyosin receptor kinase b resulting in the phosphorylation of erk extracellular signal regulated kinase mapks mitogen activated protein kinases and akt [also called pkb protein kinase b ].
6879MAPK6mitogen-activated protein kinase 6extracellular signal regulated kinase1.0released bdnf then activates its high affinity receptor trkb tropomyosin receptor kinase b resulting in the phosphorylation of erk extracellular signal regulated kinase mapks mitogen activated protein kinases and akt [also called pkb protein kinase b ].
4571GRIA1glutamate receptor, ionotropic, AMPA 1glutamate receptor1.0we postulate that these activated kinases phosphorylate glutamate receptors inducing glutamate receptor trafficking inserting more receptors in the post synaptic membrane and strengthening synapses between glutamatergic brainstem respiratory neurons and phrenic motor neurons.
9391PRKAR2Aprotein kinase, cAMP-dependent, regulatory, type II, alphaprotein kinase a1.0for example pka protein kinase a and pkc both modulate basal respiratory drive currents in medullary respiratory neurons including expiratory neurons in the caudal medulla [ 31 32 ] inspiratory neurons in the pre b_amp_#246;tzinger
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0ros are continuously generated in cells through enzymatic e.g nadph oxidase and xanthine oxidase and non enzymatic e.g mitochondrial electron transport chain and receptor activation processes [ 46 ].
12805XDHxanthine dehydrogenasexanthine oxidase1.0ros are continuously generated in cells through enzymatic e.g nadph oxidase and xanthine oxidase and non enzymatic e.g mitochondrial electron transport chain and receptor activation processes [ 46 ].
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))superoxide dismutase1.0sod superoxide dismutase ] prevent excessive ros accumulation [ 46 ].
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase may generate the ros necessary for pltf since apocynin an nadph oxidase and superoxide anion inhibitor blocks pltf [ 24 ].
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0indeed putative phrenic motor neurons and nearby astrocytes express subunits of the nadph oxidase complex i satriotomo p.m macfarlane d.j harrigan and g.s mitchell unpublished work .
9308PPP2R4protein phosphatase 2A activator, regulatory subunit 4protein phosphatase 2a1.0indeed in vitro application of h 2 o 2 to cervical spinal cord homogenates significantly inhibits the activity of the okadaic acid sensitive serine/threonine phosphatase protein phosphatase 2a j.e.r wilkerson and g.s mitchell unpublished work .
727ARTNarteminneurotrophic factor1.0key words: brain derived neurotrophic factor bdnf 5 hydroxytryptamine 5 ht long term facilitation pattern sensitivity phosphorylation plasticity.
1033BDNFbrain-derived neurotrophic factorbrain derived neurotrophic factor1.0key words: brain derived neurotrophic factor bdnf 5 hydroxytryptamine 5 ht long term facilitation pattern sensitivity phosphorylation plasticity.
727ARTNarteminneurotrophic factor1.0abbreviations used: aih acute intermittent hypoxia; bdnf brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxyg
9391PRKAR2Aprotein kinase, cAMP-dependent, regulatory, type II, alphaprotein kinase a1.0ns used: aih acute intermittent hypoxia; bdnf brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxygen species; sod superoxide dismutase; trkb tropomyosin receptor kinase b.
391AKT1v-akt murine thymoma viral oncogene homolog 1protein kinase b1.0ermittent hypoxia; bdnf brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxygen species; sod superoxide dismutase; trkb tropomyosin receptor kinase b.
9393PRKCAprotein kinase C, alphaprotein kinase c1.0f brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxygen species; sod superoxide dismutase; trkb tropomyosin receptor kinase b.
6879MAPK6mitogen-activated protein kinase 6extracellular signal regulated kinase1.0abbreviations used: aih acute intermittent hypoxia; bdnf brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxygen species; sod superoxide dismutase; trkb
1033BDNFbrain-derived neurotrophic factorbrain derived neurotrophic factor1.0abbreviations used: aih acute intermittent hypoxia; bdnf brain derived neurotrophic factor; erk extracellular signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxyg
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))superoxide dismutase1.0lar signal regulated kinase; 5 ht 5 hydroxytryptamine; ltf long term facilitation; pltf phrenic ltf; pka protein kinase a; pkb protein kinase b; pkc protein kinase c; ros reactive oxygen species; sod superoxide dismutase; trkb tropomyosin receptor kinase b.